Pharmacological regulators of autophagy and their link with modulators of lupus disease

British Journal of Pharmacology

Volumn 171, Issue 19, 2014, Pages 4337-4359

  Gros, Frédéric ^a,b   Muller, Sylviane ^a,b  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 AMINO 1 ISOPROPYL 1H PYRAZOLO[3,4 D]PYRIMIDIN 3 YL) 1H INDOL 5 OL; 2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; 4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CARBAMAZEPINE; CLONIDINE; CYTOCHROME C OXIDASE; DEXAMETHASONE; HYDROXYCHLOROQUINE; INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METFORMIN; NICLOSAMIDE; P 140 PEPTIDE; PACLITAXEL; RAPAMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTTLERIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); TORIN 1; TREHALOSE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; WORTMANNIN; XESTOSPONGIN B;

ANTIGEN PRESENTATION; AUTOIMMUNITY; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CELL STRESS; CELL SURVIVAL; CHAPERONE-MEDIATED AUTOPHAGY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGRADATION; DOWN REGULATION; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ENERGY BALANCE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MACROAUTOPHAGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; VIRUS REPLICATION; ANIMAL; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; AUTOPHAGY; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84925612331     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12792     Document Type: Review

References (186)

1. Aichinger M, Wu C, Nedjic J, Klein L, (2013). Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J Exp Med 210: 287-300.
2. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, et al. (2012). T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 26: 4722-4732.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
6. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. Br J Pharmacol 170: 1676-1705.
7. Ali AB, Nin DS, Tam J, Khan M, (2011). Role of chaperone mediated autophagy (CMA) in the degradation of misfolded N-CoR protein in non-small cell lung cancer (NSCLC) cells. PLoS ONE 6: e25268.
8. Alinari L, Mahoney E, Patton J, Zhang X, Huynh L, Earl CT, et al. (2011). FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death. Blood 118: 6893-6903.
9. Alirezaei M, Fox HS, Flynn CT, Moore CS, Hebb AL, Frausto RF, et al. (2009). Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy 5: 152-158.
10. Anguiano J, Garner TP, Mahalingam M, Das BC, Gavathiotis E, Cuervo AM, (2013). Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat Chem Biol 9: 374-382.
11. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, et al. (2009). mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
12. Araki K, Ellebedy AH, Ahmed R, (2011). TOR in the immune system. Curr Opin Cell Biol 23: 707-715.
13. Ashrafi G, Schwarz TL, (2013). The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20: 31-42.
14. Auteri JS, Okada A, Bochaki V, Dice JF, (1983). Regulation of intracellular protein degradation in IMR-90 human diploid fibroblasts. J Cell Physiol 115: 167-174.
15. Baek KH, Park J, Shin I, (2012). Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 41: 3245-3263.
16. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, et al. (2009). Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS ONE 4: e7124.
17. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM, (2008). The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 28: 5747-5763.
18. Birgisdottir AB, Lamark T, Johansen T, (2013). The LIR motif-crucial for selective autophagy. J Cell Sci 126: 3237-3247.
19. Blum JS, Wearsch PA, Cresswell P, (2013). Pathways of antigen processing. Annu Rev Immunol 31: 443-473.
20. Brazil MI, Weiss S, Stockinger B, (1997). Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur J Immunol 27: 1506-1514.
21. Caro LH, Plomp PJ, Wolvetang EJ, Kerkhof C, Meijer AJ, (1988). 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur J Biochem 175: 325-329.
22. Castillo EF, Dekonenko A, Arko-Mensah J, Mandell MA, Dupont N, Jiang S, et al. (2012). Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci U S A 109: E3168-E3176.
23. Cemma M, Brumell JH, (2012). Interactions of pathogenic bacteria with autophagy systems. Curr Biol 22: R540-R545.
24. Chaturvedi A, Dorward D, Pierce SK, (2008). The B cell receptor governs the subcellular location of toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28: 799-809.
25. Cheong H, Lu C, Lindsten T, Thompson CB, (2012). Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 30: 671-678.
26. Chiang HL, Dice JF, (1988). Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J Biol Chem 263: 6797-6805.
27. Choi AMK, Ryter SW, Levine B, (2013). Autophagy in human health and disease. N Engl J Med 368: 651-662.
28. Christian P, Sacco J, Adeli K, (2013). Autophagy: emerging roles in lipid homeostasis and metabolic control. Biochim Biophys Acta 1831: 819-824.
29. Clarke AJ, Ellinghaus U, Cortini A, Stranks A, Simon AK, Botto M, et al. (2014). Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Ann Rheum Dis [Epub ahead of print].
30. Codogno P, Mehrpour M, Proikas-Cezanne T, (2012). Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 13: 7-12.
31. Connor AM, Mahomed N, Gandhi R, Keystone EC, Berger SA, (2012). TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 14: R62.
32. Conway KL, Kuballa P, Khor B, Zhang M, Shi HN, Virgin HW, et al. (2013). ATG5 regulates plasma cell differentiation. Autophagy 9: 528-537.
33. Crotzer VL, Blum JS, (2010). Autophagy and adaptive immunity. Immunology 131: 9-17.
34. Cuervo AM, Dice JF, (1996). A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273: 501-503.
35. Cuervo AM, Wong E, (2014). Chaperone-mediated autophagy: roles in disease and aging. Cell Res 24: 92-104.
36. Cuervo AM, Dice JF, Knecht E, (1997). A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 272: 5606-5615.
37. Davies DM, Beedie MA, Rawlins MD, (1975). Antinuclear antibodies during procainamide treatment and drug acetylation. Br Med J 3: 682-684.
38. Decuypere JP, Paudel RC, Parys J, Bultynck G, (2013). Intracellular Ca(2+) signaling: a novel player in the canonical mTOR-controlled autophagy pathway. Commun Integr Biol 6: e25429.
39. Demarchi F, Bertoli C, Copetti T, Tanida I, Brancolini C, Eskelinen EL, et al. (2006). Calpain is required for macroautophagy in mammalian cells. J Cell Biol 175: 595-605.
40. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Muller M, et al. (2005). Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A 102: 7922-7927.
41. Deretic V, Saitoh T, Akira S, (2013). Autophagy in infection, inflammation and immunity. Nat Rev Immunol 13: 722-737.
42. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW, (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 22: 239-251.
43. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, et al. (2012). Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12: 22-30.
44. Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al. (2006). Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 116: 2161-2172.
45. Farkas T, Daugaard M, Jaattela M, (2011). Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. J Biol Chem 286: 38904-38912.
46. Feng Y, He D, Yao Z, Klionsky DJ, (2014). The machinery of macroautophagy. Cell Res 24: 24-41.
47. Fiegl D, Kagebein D, Liebler-Tenorio EM, Weisser T, Sens M, Gutjahr M, et al. (2013). Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells. J Immunol 190: 2791-2806.
48. Finn PF, Mesires NT, Vine M, Dice JF, (2005). Effects of small molecules on chaperone-mediated autophagy. Autophagy 1: 141-145.
49. Fleming A, Noda T, Yoshimori T, Rubinsztein DC, (2011). Chemical modulators of autophagy as biological probes and potential therapeutics. Nat Chem Biol 7: 9-17.
50. Flossmann O, Jayne DR, (2010). Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualin. Rheumatology (Oxford) 49: 556-562.
51. Foad B, Litwin A, Zimmer H, Hess EV, (1977). Acetylator phenotype in systemic lupus erythematosus. Arthritis Rheum 20: 815-818.
52. Francipane MG, Lagasse E, (2013). Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1. Oncotarget 4: 1948-1962.
53. Ganley IG, Wong PM, Gammoh N, Jiang X, (2011). Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 42: 731-743.
54. Gao S, Yang XJ, Zhang WG, Ji YW, Pan Q, (2009). Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chin Med J (Engl) 122: 1260-1266.
55. Gianchecchi E, Delfino DV, Fierabracci A, (2014). Recent insights on the putative role of autophagy in autoimmune diseases. Autoimmun Rev 13: 231-241.
56. Gordon PB, Holen I, Fosse M, Rotnes JS, Seglen PO, (1993). Dependence of hepatocytic autophagy on intracellularly sequestered calcium. J Biol Chem 268: 26107-26112.
57. Gros F, Arnold J, Page N, Decossas M, Korganow AS, Martin T, et al. (2012). Macroautophagy is deregulated in murine and human lupus T lymphocytes. Autophagy 8: 1113-1123.
58. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226.
59. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. (2008). Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210.
60. Harr MW, McColl KS, Zhong F, Molitoris JK, Distelhorst CW, (2010). Glucocorticoids downregulate Fyn and inhibit IP(3)-mediated calcium signaling to promote autophagy in T lymphocytes. Autophagy 6: 912-921.
61. Harris J, (2011). Autophagy and cytokines. Cytokine 56: 140-144.
62. He LQ, Lu JH, Yue ZY, (2013). Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin 34: 605-611.
63. Henault J, Martinez J, Riggs Jeffrey M, Tian J, Mehta P, Clarke L, et al. (2012). Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37: 986-997.
64. Hoang B, Benavides A, Shi Y, Yang Y, Frost P, Gera J, et al. (2012). The PP242 mammalian target of rapamycin (mTOR) inhibitor activates extracellular signal-regulated kinase (ERK) in multiple myeloma cells via a target of rapamycin complex 1 (TORC1)/eukaryotic translation initiation factor 4E (eIF-4E)/RAF pathway and activation is a mechanism of resistance. J Biol Chem 287: 21796-21805.
65. Hoyer-Hansen M, Jaattela M, (2007). Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ 14: 1576-1582.
66. Huang J, Brumell JH, (2014). Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12: 101-114.
67. Hubbard VM, Valdor R, Patel B, Singh R, Cuervo AM, Macian F, (2010). Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 185: 7349-7357.
68. Ireland JM, Unanue ER, (2011). Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J Exp Med 208: 2625-2632.
69. Jarvinen TM, Hellquist A, Zucchelli M, Koskenmies S, Panelius J, Hasan T, et al. (2012). Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. Rheumatology (Oxford) 51: 87-92.
70. Jewell JL, Russell RC, Guan KL, (2013). Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14: 133-139.
71. Jia W, He YW, (2011). Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy. J Immunol 186: 5313-5322.
72. Jia W, Pua HH, Li QJ, He YW, (2011). Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. J Immunol 186: 1564-1574.
73. Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, et al. (2010). Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res 70: 2516-2527.
74. Kang R, Zeh HJ, Lotze MT, Tang D, (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18: 571-580.
75. Kasai M, Tanida I, Ueno T, Kominami E, Seki S, Ikeda T, et al. (2009). Autophagic compartments gain access to the MHC class II compartments in thymic epithelium. J Immunol 183: 7278-7285.
76. Kaushik S, Cuervo AM, (2012). Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22: 407-417.
77. Kawada M, Masuda T, Ishizuka M, Takeuchi T, (2002). 15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis. J Biol Chem 277: 27765-27771.
78. Kimmelman AC, (2011). The dynamic nature of autophagy in cancer. Genes Dev 25: 1999-2010.
79. Kirkin V, McEwan DG, Novak I, Dikic I, (2009). A role for ubiquitin in selective autophagy. Mol Cell 34: 259-269.
80. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
81. Kon M, Cuervo AM, (2010). Chaperone-mediated autophagy in health and disease. FEBS Lett 584: 1399-1404.
82. Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, et al. (2006). Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10: 375-388.
83. Kovacs JR, Li C, Yang Q, Li G, Garcia IG, Ju S, et al. (2012). Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ 19: 144-152.
84. Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R, (2011). Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol 186: 4794-4804.
85. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, et al. (2010). In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32: 227-239.
86. Li C, Capan E, Zhao Y, Zhao J, Stolz D, Watkins SC, et al. (2006). Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J Immunol 177: 5163-5168.
87. Li M, Khambu B, Zhang H, Kang JH, Chen X, Chen D, et al. (2013). Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem 288: 35769-35780.
88. Li Y, Wang LX, Yang G, Hao F, Urba WJ, Hu HM, (2008). Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 68: 6889-6895.
89. Liang Q, Seo GJ, Choi YJ, Kwak MJ, Ge J, Rodgers MA, et al. (2014). Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell Host Microbe 15: 228-238.
90. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
91. Liu WT, Lin CH, Hsiao M, Gean PW, (2011). Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy 7: 166-175.
92. Lorenz HM, Grunke M, Wendler J, Heinzel PA, Kalden JR, (2005). Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus. Ann Rheum Dis 64: 1517-1519.
93. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237-248.
94. Maeda K, Umeda Y, Saino T, (1993). Synthesis and background chemistry of 15-deoxyspergualin. Ann N Y Acad Sci 685: 123-135.
95. Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Marino G, et al. (2011). BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 30: 3918-3929.
96. Manning BD, Cantley LC, (2003). Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28: 573-576.
97. Marino G, Niso-Santano M, Baehrecke EH, Kroemer G, (2014). Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol 15: 81-94.
98. Marquez RT, Xu L, (2012). Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2: 214-221.
99. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P, et al. (2011). Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci U S A 108: 17396-17401.
100. Marzano AV, Vezzoli P, Crosti C, (2009). Drug-induced lupus: an update on its dermatologic aspects. Lupus 18: 935-940.
101. Mihaylova MM, Shaw RJ, (2011). The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023.
102. Miller BC, Zhao Z, Stephenson LM, Cadwell K, Pua HH, Lee HK, et al. (2008). The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4: 309-314.
103. Mizushima N, Yoshimori T, Levine B, (2010). Methods in mammalian autophagy research. Cell 140: 313-326.
104. Molitoris JK, McColl KS, Swerdlow S, Matsuyama M, Lam M, Finkel TH, et al. (2011). Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J Biol Chem 286: 30181-30189.
105. Monneaux F, Muller S, (2009). Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects. Arthritis Res Ther 11: 234.
106. Monneaux F, Lozano JM, Patarroyo ME, Briand JP, Muller S, (2003). T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol 33: 287-296.
107. Morselli E, Marino G, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, et al. (2011). Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol 192: 615-629.
108. Muller S, Wallace D, (2014). The importance of implementing proper selection of excipients in lupus clinical trials. Lupus [Epub ahead of print].
109. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230.
110. Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L, (2008). Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 455: 396-400.
111. Nixon RA, (2013). The role of autophagy in neurodegenerative disease. Nat Med 19: 983-997.
112. Ohlman S, Zilg H, Schindel F, Lindholm A, (1994). Pharmacokinetics of 15-deoxyspergualin studied in renal transplant patients receiving the drug during graft rejection. Transpl Int 7: 5-10.
113. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, et al. (2002). Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J Rheumatol 29: 707-716.
114. Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, et al. (2013). Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16: 394-406.
115. Orozco G, Eyre S, Hinks A, Bowes J, Morgan AW, Wilson AG, et al. (2011). Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 70: 463-468.
116. Page N, Gros F, Schall N, Decossas M, Bagnard D, Briand JP, et al. (2011). HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus. Ann Rheum Dis 70: 837-843.
117. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, et al. (2005). Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307: 593-596.
118. Parekh VV, Wu L, Boyd KL, Williams JA, Gaddy JA, Olivares-Villagomez D, et al. (2013). Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. J Immunol 190: 5086-5101.
119. Paul S, Kashyap AK, Jia W, He YW, Schaefer BC, (2012). Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB. Immunity 36: 947-958.
120. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Research 42 (Database Issue): D1098-1106.
121. Pengo N, Scolari M, Oliva L, Milan E, Mainoldi F, Raimondi A, et al. (2013). Plasma cells require autophagy for sustainable immunoglobulin production. Nat Immunol 14: 298-305.
122. Pierdominici M, Vomero M, Barbati C, Colasanti T, Maselli A, Vacirca D, et al. (2012). Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J 26: 1400-1412.
123. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW, (2007). A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 204: 25-31.
124. Pua HH, Guo J, Komatsu M, He YW, (2009). Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J Immunol 182: 4046-4055.
125. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. (2010). Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435.
126. Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R, et al. (2011). Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 21: 290-304.
127. Ren X, Duan L, He Q, Zhang Z, Zhou Y, Wu D, et al. (2010). Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Med Chem Lett 1: 454-459.
128. Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC, (2010). Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285: 11061-11067.
129. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, et al. (2011). Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 121: 3554-3563.
130. Richetta C, Faure M, (2013). Autophagy in antiviral innate immunity. Cell Microbiol 15: 368-376.
131. Romao S, Gasser N, Becker AC, Guhl B, Bajagic M, Vanoaica D, et al. (2013). Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. J Cell Biol 203: 757-766.
132. Rooswinkel RW, van de Kooij B, Verheij M, Borst J, (2012). Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis 3: e366.
133. Rubinsztein DC, Codogno P, Levine B, (2012). Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11: 709-730.
134. Russell RC, Yuan HX, Guan KL, (2014). Autophagy regulation by nutrient signaling. Cell Res 24: 42-57.
135. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, et al. (2009). Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A 106: 20842-20846.
136. Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, et al. (2013). Impaired autophagy and APP processing in Alzheimer's disease: the potential role of Beclin 1 interactome. Prog Neurobiol 106-107: 33-54.
137. Sarkar S, Rubinsztein DC, (2008). Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst 4: 895-901.
138. Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC, (2007a). Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282: 5641-5652.
139. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, et al. (2007b). Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 3: 331-338.
140. Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC, (2009). Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16: 46-56.
141. Schlienger RG, Bircher AJ, Meier CR, (2000). Minocycline-induced lupus. A systematic review. Dermatology 200: 223-231.
142. Schmid D, Pypaert M, Munz C, (2007). Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26: 79-92.
143. Schur PH, (1995). Genetics of systemic lupus erythematosus. Lupus 4: 425-437.
144. Shaw PJ, McDermott MF, Kanneganti TD, (2011). Inflammasomes and autoimmunity. Trends Mol Med 17: 57-64.
145. Shimobayashi M, Hall MN, (2014). Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15: 155-162.
146. Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, et al. (2013). Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494: 201-206.
147. Singh BN, Kumar D, Shankar S, Srivastava RK, (2012). Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol 84: 1154-1163.
148. Stephenson LM, Miller BC, Ng A, Eisenberg J, Zhao Z, Cadwell K, et al. (2009). Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. Autophagy 5: 625-635.
149. Stricher F, Macri C, Ruff M, Muller S, (2013). HSPA8/HSC70 chaperone protein: structure, function, and chemical targeting. Autophagy 9: 1937-1954.
150. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. (2013). Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4: e838.
151. Sumpter MD, Tatro LS, Stoecker WV, Rader RK, (2012). Evidence for risk of cardiomyopathy with hydroxychloroquine. Lupus 21: 1594-1596.
152. Swerdlow S, McColl K, Rong Y, Lam M, Gupta A, Distelhorst CW, (2008). Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes. Autophagy 4: 612-620.
153. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A, (2009). Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A 106: 2770-2775.
154. Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, et al. (2004). Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10: 148-154.
155. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT, (2012). PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249: 158-175.
156. Tey SK, Khanna R, (2012). Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood 120: 994-1004.
157. Thome R, Issayama LK, Digangi R, Bombeiro AL, da Costa TA, Ferreira IT, et al. (2014). Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis. Immunol Cell Biol 92: 124-132.
158. Thomson AW, Turnquist HR, Raimondi G, (2009). Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
159. Thoreen CC, Sabatini DM, (2009). Rapamycin inhibits mTORC1, but not completely. Autophagy 5: 725-726.
160. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, et al. (2009). An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023-8032.
161. Towns R, Kabeya Y, Yoshimori T, Guo C, Shangguan Y, Hong S, et al. (2005). Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 1: 163-170.
162. Tsukada M, Ohsumi Y, (1993). Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333: 169-174.
163. Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML, (2009). Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 16: 991-1005.
164. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH, (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323.
165. Vedove C, Giglio M, Schena D, Girolomoni G, (2009). Drug-induced lupus erythematosus. Arch Dermatol Res 301: 99-105.
166. Veldhoen RA, Banman SL, Hemmerling DR, Odsen R, Simmen T, Simmonds AJ, et al. (2013). The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis. Oncogene 32: 736-746.
167. Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, et al. (2009). The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ 16: 1006-1017.
168. Wang YC, Chao TK, Chang CC, Yo YT, Yu MH, Lai HC, (2013). Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells. PLoS ONE 8: e74538.
169. Watson RO, Manzanillo PS, Cox JS, (2012). Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150: 803-815.
170. Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, et al. (2008). Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4: 295-305.
171. Willinger T, Flavell RA, (2012). Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis. Proc Natl Acad Sci U S A 109: 8670-8675.
172. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, et al. (2010). Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 285: 10850-10861.
173. Xie M, Morales CR, Lavandero S, Hill JA, (2011). Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol 26: 216-222.
174. Xie R, Nguyen S, McKeehan WL, Liu L, (2010). Acetylated microtubules are required for fusion of autophagosomes with lysosomes. BMC Cell Biol 11: 89.
175. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y, (1998). Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23: 33-42.
176. Yang Z, Klionsky DJ, (2010). Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822.
177. Yang Z, Fujii H, Mohan SV, Goronzy JJ, Weyand CM, (2013). Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med 210: 2119-2134.
178. You S, Li R, Park D, Xie M, Sica GL, Cao Y, et al. (2014). Disruption of STAT3 by niclosamide reverses radioresistance of human lung vancer. Mol Cancer Ther 13: 606-616.
179. Yue Z, Jin S, Yang C, Levine AJ, Heintz N, (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100: 15077-15082.
180. Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, et al. (2007). Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A 104: 19023-19028.
181. Zhou D, Li P, Lin Y, Lott JM, Hislop AD, Canaday DH, et al. (2005). Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22: 571-581.
182. Zhou R, Yazdi AS, Menu P, Tschopp J, (2011a). A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225.
183. Zhou XJ, Zhang H, (2012). Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy 8: 1286-1299.
184. Zhou XJ, Lu XL, Lv JC, Yang HZ, Qin LX, Zhao MH, et al. (2011b). Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis 70: 1330-1337.
185. Zimmer R, Scherbarth HR, Rillo OL, Gomez-Reino JJ, Muller S, (2013). Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial. Ann Rheum Dis 72: 1830-1835.
186. Zinn RL, Gardner EE, Dobromilskaya I, Murphy S, Marchionni L, Hann CL, et al. (2013). Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer 12: 16.